UEMS medicinsk specialitet

Psykiatri och neuropsykiatri — Sida 2

Formulation science addressing mental health: catecholaminergic modulation, ADHD, mood disorders, neuropsychological function, and the gut–brain axis as a therapeutic target.

25

dossierer

Precisionsmikrobiom & tarm-hjärna-axeln

Tarm-hjärna-axeln vid ADHD: Mikrobiota-medierad modulering av dopaminerga signalvägar

Att utveckla vetenskapligt validerade mikrobiom-riktade interventioner för ADHD innebär att hantera utmaningar med heterogenitet i kliniska utfall och att identifiera exakta mikrobiella mekanismer. Att formulera stabila, effektiva probiotika eller synbiotika med påvisade kliniska fördelar förblir ett betydande hinder.

NeuroinflammationAttention Deficit Disorder with HyperactivityDopamineSerotonin

Anpassad formulering tillgänglig

Behöver du en dossier framtagen för din molekyl?

Project-specific requirements and next steps are confirmed in writing through the agreed scope.

Request a written scoped quote← Återgå till Clinical Matrix

RELATED RESOURCES

R&D Hub — All Scientific CategoriesFull library of evidence-based research covering formulation, bioavailability and clinical nutrition.EXPLORE ›Advanced Formulation Technology PlatformProject-specific formulation assessment, evidence review and regulatory pathway are defined in the agreed scope. Manufacturing arrangements and any external testing are confirmed per project.EXPLORE ›Production Formats & MOQ ReferenceHard capsules 150K, softgels 300K, sachets 75K — connect the science to actual industrial thresholds.EXPLORE ›Physician Supplement Brand Contract ManufacturingA project brief defines the formulation, evidence, regulatory path, scope and ownership terms before manufacturing is considered.EXPLORE ›Paid Discovery: R&D Due Diligence EntryTransform research findings into a scoped, confidential manufacturing brief.EXPLORE ›Commercialization Intelligence HubRegulatory and market strategy intelligence for supplement brand decision-makers.EXPLORE ›